Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections
- Conditions
- Dry Eye
- Registration Number
- NCT04458012
- Lead Sponsor
- Helse Stavanger HF
- Brief Summary
To investigate prevalence of dry eye disease in Norwegian patients with age-related macular degeneration receiving intravitreal injections, as well as to reveal possible risk factors of DED in this population.
- Detailed Description
Questionaires (OSDI, McMonnies) and clinical investigation using the Oculus 5 Keratograph for objective ocular surface evaluation. Tear fluid samples will be collected for later biochemical analysis.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- AMD diagnosis
- Treated with intravitreal injection agents
Read More
Exclusion Criteria
- Not able to cooperate
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dry eye disease in patients receiving intravitreal injections 2022
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stavanger University Hospital, Department of Ophthalmology
🇳🇴Stavanger, Norway